/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Trevena Inc Share Price Today: Live Updates & Key Insights

Trevena Inc share price today is $2.475, up -46.25%. The stock opened at $2.44 against the previous close of $4.605, with an intraday high of $2.67 and low of $2.37.

Trevena Inc Share Price Chart

style
pb-0

Trevena Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Trevena Inc Share Price Performance

$2.475 -0.4625(-46.25%) TRVN at 13 Mar 2026 03:35 PM Biotechnology
Lowest Today 2.37
Highest Today 2.67
Today’s Open 2.44
Prev. Close 4.605
52 Week High 19.23
52 Week Low 3.35
Day’s Range: Low 2.37 High 2.67
52-Week Range: Low 3.35 High 19.23
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

Trevena Inc Institutional Holdings

BlackRock Inc 0.64

Renaissance Technologies Corp 0.62

Geode Capital Management, LLC 0.54

Fidelity Extended Market Index 0.39

Vanguard Group Inc 0.34

Vanguard Institutional Extnd Mkt Idx Tr 0.34

Baader Bank INC 0.12

State Street Corp 0.12

Vifag 2002 SICAV 0.11

FMR Inc 0.10

Fidelity OTC 0.08

BlackRock Extended Equity Market K 0.08

Summit X, LLC 0.08

Northern Trust Corp 0.05

Morgan Stanley - Brokerage Accounts 0.05

Fidelity Total Market Index 0.04

Fidelity Nasdaq Composite Index 0.04

Fidelity Series Total Market Index 0.03

Spartan Total Market Index Pool E 0.03

NT Ext Equity Mkt Idx Fd - NL 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.02

Northern Trust Extended Eq Market Idx 0.02

NT Ext Equity Mkt Idx Fd - L 0.02

SSgA U.S. Extended Market Index Class I 0.01

State St US Extended Mkt Indx NL Cl C 0.01

Fidelity® OTC Commingled Pool Class O 0.01

BNYM Mellon SL Market Completion UC1 0.01

Extended Equity Market Fund M 0.01

Fidelity OTC K6 0.01

SSgA U.S. Total Market Index Strategy 0.01

Bank of America Corp 0.00

JPMorgan Chase & Co 0.00

Wells Fargo & Co 0.00

Activest Wealth Management 0.00

Planning Capital Management Corp 0.00

OLD POINT TRUST & FINANCIAL SERVICES N A 0.00

Royal Bank of Canada 0.00

Financial Perspectives Inc 0.00

SignatureFD, LLC 0.00

UBS Group AG 0.00

Trevena Inc Market Status

Strong Buy: 0

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Trevena Inc Fundamentals

Market Cap 3.93 M

PB Ratio 0.3564

PE Ratio 0.0

Enterprise Value 23.52 M

Total Assets 40.61 M

Volume 265804

Trevena Inc Company Financials

Annual Revenue FY23:3207000 3.2M, FY22:-418000 -0.4M, FY21:567000 0.6M, FY20:3069000 3.1M, FY19:31000 0.0M

Annual Profit FY23:2591000 2.6M, FY22:-3436000 -3.4M, FY21:-387000 -0.4M, FY20:2887000 2.9M, FY19:-77000 -0.1M

Annual Net worth FY23:-30738000 -30.7M, FY22:-53667295 -53.7M, FY21:-51160000 -51.2M, FY20:-29369000 -29.4M, FY19:-28056000 -28.1M

Quarterly Revenue Q2/2024:325000 0.3M, Q1/2024:20000 0.0M, Q3/2023:180000 0.2M, Q2/2023:3021000 3.0M, Q1/2023:6000 0.0M

Quarterly Profit Q2/2024:133000 0.1M, Q1/2024:-156000 -0.2M, Q3/2023:5000 0.0M, Q2/2023:2933000 2.9M, Q1/2023:-121000 -0.1M

Quarterly Net worth Q2/2024:-4891000 -4.9M, Q1/2024:-7678000 -7.7M, Q3/2023:-7930000 -7.9M, Q2/2023:-8012000 -8.0M, Q1/2023:-5965000 -6.0M

About Trevena Inc & investment objective

Company Information Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Organisation Biotechnology

Employees 23

Industry Biotechnology

CEO Ms. Carrie L. Bourdow

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow